The autoimmune process in Hashimoto's disease is distinct from the mechanisms affected by GLP-1 therapy, and no causal relationship has been established in clinical studies or post-marketing surveillance
Definitive genetic validation using MT1- or MT2-deficient ILC2s remains an important next step in confirming that melatonin acts on ILC2s independent of canonical melatonin receptors
So if you apply, it's like if you apply the same intervention to a group of people, some have a lot of excess weight, some don't
For women of childbearing potential, these medications are not recommended during pregnancy or breastfeeding, and discontinuation is advised at least 2 months before planned pregnancy for semaglutide and 1 month for tirzepatide
Breastfeeding parents typically need: About 2,000 calories per day for baseline metabolism An additional ~250 calories or more for milk production If appetite suppression leads to inadequate calorie intake, this can result in: Reduced milk supply Dehydration Fatigue or dizziness Nutrient deficiencies Potential changes in breast milk nutrient composition In other words, the primary concern during breastfeeding is maintaining adequate nutrition not medication exposure in milk
Your dose may increase as your provider adjusts your therapy